Cofepris: Warns of irregular marketing of Tempra infant syrup

The Federal Commission for the Protection against Sanitary Risks (Cofepris) alerted the general population through a statement, on the irregular marketing of the product Tempra® (Paracetamol) 3.2 g/100 mL children's syrup, presented in a cardboard box with a labeled bottle with 120 mL (3.2 g/100 mL) and a measuring cup.

This health alert is issued as a result of the technical documentary analysis of the information sent by the company RB SALUTE MÉXICO SA de CV, holder of the health registration, who informed Cofepris that the following batches of the product Tempra® (Paracetamol) 3.2 g/100mL are outside the specifications of the quality standards, and therefore were not marketed or distributed and instead were sent for destruction:

READ: Biometric CURP: Why will it be an unforgeable document?

However, lots ABD0574, ABD0575, ABD0577, ABD0850 were found for sale on the public highway at a street market. , therefore, the handling, transportation and storage conditions of these substances are unknown, which could modify their characteristics and not provide the desired therapeutic effect, putting the health of patients at risk.

In addition, lots ABB0151 expiration April 2026, ABA9847 expiration June 2026 and ABB2255 expiration Aug 2026 were identified for sale. , which were intended as gift samples, so they should not be marketed.

You may be interested in: Sheinbaum speaks about the accusations against former Governor Diego Sinhue

Therefore, Cofepis issues the following recommendations:

Do not purchase or use Tempra® (Paracetamol) 3.2 g/100 mL infant syrup from the lot numbers listed above , as they pose a health risk.

If you identify the sale of products with the aforementioned batches and have information about their possible commercialization, file the corresponding health report.

Never buy medicines on public streets or in informal stores, such as street vendors, stalls, and street vendors. Cofepris provides information on the risks of purchasing medications from unauthorized establishments.

If there is any doubt about its originality, contact the holder of the health registration to confirm the identity. To identify the holder, you can consult the Health Registration Query page.

If you used the aforementioned product and experience any adverse reaction or discomfort, it is important to report it at the following online link or by email: [email protected]

*Stay up to date with the news, join our WhatsApp channel here: https://whatsapp.com/channel/0029VaAf9Pu9hXF1EJ561i03